The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared.

BACKGROUND Antidepressants are commonly prescribed by general practitioners as treatment for depression. Controversy exists as to the effectiveness in everyday use of the older tricyclic antidepressants (TCAs) when compared to the newer selective serotonin reuptake inhibitors (SSRIs). AIM To investigate the patterns of current prescribing of antidepressants for the treatment of depression and compare TCAs with the newer SSRIs. METHOD The study population was patients attending 151 computerised general practices from throughout the United Kingdom between 1991 and 1996. Patients with new prescriptions for antidepressants and a diagnosis of depression were identified. Age and gender distributions, prescribed doses and drop-out rates were investigated. RESULTS During the study period 9.8% of patients received a prescription for an antidepressant, there was a 40% increase in the prescribing rate of TCAs and a 460% increase in SSRI prescribing. TCAs were initially prescribed in sub-therapeutic doses. More than 50% of patients ceased taking their antidepressants within 6 weeks of starting treatment. Fluoxetine and paroxetine were more likely to be prescribed for a therapeutic period than were other antidepressants. CONCLUSIONS General practitioners should prescribe a therapeutic dose of antidepressant for a recognised therapeutic period to ensure that patients with depression receive the most effective treatment.

[1]  R. Mowbray,et al.  Controlled Trial of Amitriptyline in General Practice , 1971, British medical journal.

[2]  B. Kupelnick,et al.  Effectiveness of antidepressants , 1999, British Journal of Psychiatry.

[3]  S. Kerry,et al.  General practitioners' perceptions of the tolerability of antidepressant drugs: a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants , 1997, BMJ.

[4]  P. Bebbington,et al.  What Price Depression? , 1994, British Journal of Psychiatry.

[5]  R G Priest,et al.  Recognition and management of depression in general practice: consensus statement. , 1992, BMJ.

[6]  M. Hotopf,et al.  Are SSRIs a Cost-Effective Alternative to Tricyclics? , 1996, British Journal of Psychiatry.

[7]  I. Anderson,et al.  Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis , 1995, BMJ.

[8]  D. Kupfer,et al.  Five-year outcome for maintenance therapies in recurrent depression. , 1990, Archives of general psychiatry.

[9]  J. Cohn,et al.  A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder. , 1989, International clinical psychopharmacology.

[10]  L. J. Wei,et al.  The Robust Inference for the Cox Proportional Hazards Model , 1989 .

[11]  J. Cohn,et al.  A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder. , 1985, The Journal of clinical psychiatry.

[12]  G. Dunbar,et al.  A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patients , 1991, British Journal of Psychiatry.

[13]  G. Fenton,et al.  Antidepressant drug use in primary care: a record linkage study in Tayside, Scotland , 1996, British medical journal.

[14]  J. Chisholm,et al.  The Read clinical classification. , 1990, BMJ.

[15]  F. Song,et al.  Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. , 1993, BMJ.

[16]  S. Kasper,et al.  Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta‐analysis , 1995, International clinical psychopharmacology.

[17]  Rand Eh.  Choosing an antidepressant to treat depression. , 1991 .

[18]  A. Tylee,et al.  The Treatment of Depression: Prescribing Patterns of Antidepressants in Primary Care in the UK , 1996, British Journal of Psychiatry.

[19]  F. Song,et al.  Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide , 1994, BMJ.